The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.
Funeral prayer for Sheikh Ahmed bin Rashid to be held on Tuesday
Sheikh Ahmed bin Rashid Al Maktoum passes away; 10-day mourning in Dubai
Abu Dhabi to host UN congress on crime and criminal justice
Abu Dhabi strengthens greenhouse gas emissions monitoring
Sharjah Ruler approves 6,700 housing support requests
